# Safety, Tolerability and Preliminary Efficacy of Unilateral Latanoprost-loaded Punctual Plug -EXP-LP

> **NCT03318146** · NA · UNKNOWN · sponsor: **Shaare Zedek Medical Center** · enrollment: 40 (estimated)

## Conditions studied

- Glaucoma
- Ocular Hypertension
- IOP

## Interventions

- **DEVICE:** drug delivery system
- **DRUG:** XALATAN®

## Key facts

- **NCT ID:** NCT03318146
- **Lead sponsor:** Shaare Zedek Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-01
- **Primary completion:** 2019-06-01
- **Final completion:** 2019-09-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2017-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03318146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03318146, "Safety, Tolerability and Preliminary Efficacy of Unilateral Latanoprost-loaded Punctual Plug -EXP-LP". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03318146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*